ΠΟΛΥΚΥΣΤΙΚΕΣ ΩΟΘΗΚΕΣ ΠΟΡΙΑ ΚΟΚΟΣ
Παραπομπές:
1. Xu D, Lu M, Liu Y, et al. An Analysis of the Clinical Medication Rules of Traditional Chinese Medicine for Polycystic Ovary Syndrome Based on Data Mining. Evidence-based Complementary and Alternative Medicine : Ecam. 2023 ;2023:6198001. DOI: 10.1155/2023/6198001. PMID: 36865746; PMCID: PMC9974250.
https://europepmc.org/article/MED/36865746
2. Lim SS, Hutchison SK, Van Ryswyk E, et al. Lifestyle changes in women with polycystic ovary syndrome. The Cochrane Database of Systematic Reviews. 2019 Mar;3:CD007506. DOI: 10.1002/14651858.cd007506.pub4. PMID: 30921477; PMCID: PMC6438659.
https://europepmc.org/article/PMC/6438659
3. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Aug 11;2:16057. doi: 10.1038/nrdp.2016.57. PMID: 27510637.
https://pubmed.ncbi.nlm.nih.gov/27510637/
4. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013 Dec 18;6:1-13. doi: 10.2147/CLEP.S37559. PMID: 24379699; PMCID: PMC3872139.
https://pubmed.ncbi.nlm.nih.gov/24379699/
5. Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry. 2020 Jun 10;11:543. doi: 10.3389/fpsyt.2020.00543. PMID: 32587538; PMCID: PMC7297942.
https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00543/full
6. Teede, H., Deeks, A. & Moran, L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8, 41 (2010). https://doi.org/10.1186/1741-7015-8-41
https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-8-41
7. De Leo, V., Musacchio, M.C., Cappelli, V. et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 14, 38 (2016). https://doi.org/10.1186/s12958-016-0173-x
https://rbej.biomedcentral.com/articles/10.1186/s12958-016-0173-x
8. Sadeeqa, Saleha; Mustafa, Tehreem; Latif, Sumaira. Polycystic Ovarian Syndrome–Related Depression in Adolescent Girls: A Review. Journal of Pharmacy And Bioallied Sciences 10(2):p 55-59, Apr–Jun 2018. | DOI: 10.4103/JPBS.JPBS_1_18
https://journals.lww.com/jpbs/Fulltext/2018/10020/Polycystic_Ovarian_Syndrome_Related_Depression_in.1.aspx
9. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2695–709. doi: 10.1210/clinem/dgaa285. PMID: 32442310; PMCID: PMC7457958.
https://pubmed.ncbi.nlm.nih.gov/32442310/
10. Ding J, Shanshan M, Mengcheng C, Danying Z, Jin Y. Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome. Evidence-based Complementary and Alternative Medicine : Ecam. 2022 ;2022:2635375. DOI: 10.1155/2022/2635375. PMID: 35600955; PMCID: PMC9122682.
https://europepmc.org/article/PMC/9122682
11. Rong A, Ta N, E L, Meng W. Add-on effect of the Guizhi Fuling formula for management of reduced fertility potential in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023 Apr 18;13:995106. doi: 10.3389/fendo.2022.995106. PMID: 37143960; PMCID: PMC10153095.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153095/
12. Luo J, Nie RQ, Lin LY. Influence of taie-35 and clomifen combined with laurel cocos poria pill on the pregnancy and psychological state of polycystic ovary syndrome patients. Drug Eval Res (2018) 41(7):1300–3. doi: 10.7501/j.issn.1674-6376.2018.07.028
https://www.cabdirect.org/globalhealth/abstract/20203190560
13. Liu M, Zhu H, Hu X, Zhu Y, Chen H. Efficacy of different forms of Guizhi Fuling Wan on reproduction and metabolism in women with polycystic ovary syndrome: A protocol for a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020 Oct 30;99(44):e22954. doi: 10.1097/MD.0000000000022954. PMID: 33126363; PMCID: PMC7598780.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598780/
14. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016 Jul;106(1):6-15. doi: 10.1016/j.fertnstert.2016.05.003. Epub 2016 May 24. PMID: 27233760.
https://pubmed.ncbi.nlm.nih.gov/27233760/
15. Jabeen A, Yamini V, Rahman Amberina A, Dinesh Eshwar M, Vadakedath S, Begum GS, Kandi V. Polycystic Ovarian Syndrome: Prevalence, Predisposing Factors, and Awareness Among Adolescent and Young Girls of South India. Cureus. 2022 Aug 12;14(8):e27943. doi: 10.7759/cureus.27943. PMID: 36120281; PMCID: PMC9464521.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464521/
16. Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18. Epub 2020 Dec 28. PMID: 33627974; PMCID: PMC7879843.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879843/
17. The Lancet Regional Health-Europe. Polycystic ovary syndrome: What more can be done for patients? Lancet Reg Health Eur. 2022 Oct 3;21:100524. doi: 10.1016/j.lanepe.2022.100524. PMID: 36406775; PMCID: PMC9666923.
https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(22)00220-4/fulltext
1. Xu D, Lu M, Liu Y, et al. An Analysis of the Clinical Medication Rules of Traditional Chinese Medicine for Polycystic Ovary Syndrome Based on Data Mining. Evidence-based Complementary and Alternative Medicine : Ecam. 2023 ;2023:6198001. DOI: 10.1155/2023/6198001. PMID: 36865746; PMCID: PMC9974250.
https://europepmc.org/article/MED/36865746
2. Lim SS, Hutchison SK, Van Ryswyk E, et al. Lifestyle changes in women with polycystic ovary syndrome. The Cochrane Database of Systematic Reviews. 2019 Mar;3:CD007506. DOI: 10.1002/14651858.cd007506.pub4. PMID: 30921477; PMCID: PMC6438659.
https://europepmc.org/article/PMC/6438659
3. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Aug 11;2:16057. doi: 10.1038/nrdp.2016.57. PMID: 27510637.
https://pubmed.ncbi.nlm.nih.gov/27510637/
4. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013 Dec 18;6:1-13. doi: 10.2147/CLEP.S37559. PMID: 24379699; PMCID: PMC3872139.
https://pubmed.ncbi.nlm.nih.gov/24379699/
5. Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry. 2020 Jun 10;11:543. doi: 10.3389/fpsyt.2020.00543. PMID: 32587538; PMCID: PMC7297942.
https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00543/full
6. Teede, H., Deeks, A. & Moran, L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8, 41 (2010). https://doi.org/10.1186/1741-7015-8-41
https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-8-41
7. De Leo, V., Musacchio, M.C., Cappelli, V. et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 14, 38 (2016). https://doi.org/10.1186/s12958-016-0173-x
https://rbej.biomedcentral.com/articles/10.1186/s12958-016-0173-x
8. Sadeeqa, Saleha; Mustafa, Tehreem; Latif, Sumaira. Polycystic Ovarian Syndrome–Related Depression in Adolescent Girls: A Review. Journal of Pharmacy And Bioallied Sciences 10(2):p 55-59, Apr–Jun 2018. | DOI: 10.4103/JPBS.JPBS_1_18
https://journals.lww.com/jpbs/Fulltext/2018/10020/Polycystic_Ovarian_Syndrome_Related_Depression_in.1.aspx
9. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2695–709. doi: 10.1210/clinem/dgaa285. PMID: 32442310; PMCID: PMC7457958.
https://pubmed.ncbi.nlm.nih.gov/32442310/
10. Ding J, Shanshan M, Mengcheng C, Danying Z, Jin Y. Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome. Evidence-based Complementary and Alternative Medicine : Ecam. 2022 ;2022:2635375. DOI: 10.1155/2022/2635375. PMID: 35600955; PMCID: PMC9122682.
https://europepmc.org/article/PMC/9122682
11. Rong A, Ta N, E L, Meng W. Add-on effect of the Guizhi Fuling formula for management of reduced fertility potential in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023 Apr 18;13:995106. doi: 10.3389/fendo.2022.995106. PMID: 37143960; PMCID: PMC10153095.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153095/
12. Luo J, Nie RQ, Lin LY. Influence of taie-35 and clomifen combined with laurel cocos poria pill on the pregnancy and psychological state of polycystic ovary syndrome patients. Drug Eval Res (2018) 41(7):1300–3. doi: 10.7501/j.issn.1674-6376.2018.07.028
https://www.cabdirect.org/globalhealth/abstract/20203190560
13. Liu M, Zhu H, Hu X, Zhu Y, Chen H. Efficacy of different forms of Guizhi Fuling Wan on reproduction and metabolism in women with polycystic ovary syndrome: A protocol for a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020 Oct 30;99(44):e22954. doi: 10.1097/MD.0000000000022954. PMID: 33126363; PMCID: PMC7598780.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598780/
14. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016 Jul;106(1):6-15. doi: 10.1016/j.fertnstert.2016.05.003. Epub 2016 May 24. PMID: 27233760.
https://pubmed.ncbi.nlm.nih.gov/27233760/
15. Jabeen A, Yamini V, Rahman Amberina A, Dinesh Eshwar M, Vadakedath S, Begum GS, Kandi V. Polycystic Ovarian Syndrome: Prevalence, Predisposing Factors, and Awareness Among Adolescent and Young Girls of South India. Cureus. 2022 Aug 12;14(8):e27943. doi: 10.7759/cureus.27943. PMID: 36120281; PMCID: PMC9464521.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464521/
16. Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18. Epub 2020 Dec 28. PMID: 33627974; PMCID: PMC7879843.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879843/
17. The Lancet Regional Health-Europe. Polycystic ovary syndrome: What more can be done for patients? Lancet Reg Health Eur. 2022 Oct 3;21:100524. doi: 10.1016/j.lanepe.2022.100524. PMID: 36406775; PMCID: PMC9666923.
https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(22)00220-4/fulltext
